Jabbour Samer F, Kechichian Elio G, Awaida Cyril J, Tomb Roland R, Nasr Marwan W
Beirut, Lebanon.
From the Departments of Plastic and Reconstructive Surgery and Dermatology, Faculty of Medicine, Saint-Joseph University Hotel Dieu de France Hospital.
Plast Reconstr Surg. 2017 Jul;140(1):9e-17e. doi: 10.1097/PRS.0000000000003429.
The "Nefertiti lift" consists of injecting the platysmal bands and the inferior border of the mandible with botulinum toxin. No clinical trial has evaluated its effect on the different lower face and neck aging components, and little is known about the clinical characteristics that predict treatment success.
Patients were injected with abobotulinumtoxinA along the inferior border of the mandible and into the platysmal bands. Using standardized preinjection and postinjection photographs, the jowls, marionette lines, oral commissures, neck volume, and platysmal bands at maximal contraction and at rest were assessed with validated photonumeric scales. In addition, the overall appearance of the lower face and neck was evaluated by the Investigators and Subjects Global Aesthetic Improvement Score. Pain and patient satisfaction rates were also evaluated.
Thirty patients were injected with a mean dose of 124.9 U of abobotulinumtoxinA per patient. Platysmal bands at rest and with maximal tension reached a statistically significant improvement. The other components showed a tendency for improvement but did not reach statistical significance; 93.3 percent of investigators and patients rated the overall results as improved, and 96.6 percent of patients were satisfied with their results. When comparing the patients who improved the most to all the other patients, they had lower preinjection region-specific scores.
The Nefertiti lift can be used on its own or in conjunction with other rejuvenating procedures. It is particularly helpful in younger patients with platysma muscle hyperactivity and retained skin elasticity.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
“奈费尔提蒂提升术”包括在下颌缘和颈阔肌束注射肉毒杆菌毒素。尚无临床试验评估其对不同的下面部和颈部衰老成分的影响,对于预测治疗成功的临床特征也知之甚少。
患者在下颌缘和颈阔肌束注射阿柏西普肉毒杆菌毒素A。使用标准化的注射前和注射后照片,通过经过验证的数字评分量表评估在最大收缩和静止状态下的下颌赘肉、木偶纹、口角、颈部体积和颈阔肌束。此外,由研究者和受试者通过整体美学改善评分评估下面部和颈部的整体外观。还评估了疼痛和患者满意度。
30名患者平均每人注射124.9 U阿柏西普肉毒杆菌毒素A。静止和最大张力状态下的颈阔肌束有统计学显著改善。其他成分有改善趋势,但未达到统计学显著性;93.3%的研究者和患者将总体结果评为改善,96.6%的患者对结果满意。将改善最明显的患者与所有其他患者进行比较时,前者注射前特定区域的评分较低。
奈费尔提蒂提升术可单独使用或与其他年轻化手术联合使用。它对颈阔肌活动亢进且皮肤仍有弹性的年轻患者特别有帮助。
临床问题/证据水平:治疗性,IV级。